BostonGene’s Post

Attend our poster presentations at #ESMO24 to learn more about how BostonGene's comprehensive profiling reveals potential biomarkers and therapeutic targets that expand treatment options and support biomarker-driven clinical trials. Read more: https://lnkd.in/ebep_KwS

We are proud to have received one Gold Stevie for our AI-based digital pathology platform and two Silver Stevies for our Tumor Portrait test and immune system profiling platform in the Stevie Awards for Technology Excellence, known as 'the Olympics for technology.' Read more: https://lnkd.in/ejtYrdax

Attend today’s session, "Designing More Effective Trials with Integrated Immune Profiling of Peripheral Blood and Tumor Tissue", at the 14th Annual World CB & CDx Summit. "Immunotherapy holds transformative potential in oncology, but its success depends on our ability to match the right patients with the right therapies. Our AI-powered platform enables comprehensive immune system profiling to identify key immunological signatures and resistance factors, empowering clinicians to make personalized treatment decisions. Our ultimate goal is to improve patient outcomes by guiding therapies in real-time." - Michael Goldberg, PhD, VP, Research & Development at BostonGene.

We are collaborating with Icahn School of Medicine at Mount Sinai on a prospective precision medicine study of patients with #multiplemyeloma. As part of the study, BostonGene will perform #AI-powered next-generation sequencing to uncover therapeutic vulnerabilities and drive #precisionmedicine therapies. Read more: https://lnkd.in/gZAjFzyC

Join us next week in Boston for the 14th Annual World CB & CDx Summit, where we'll demonstrate our cutting-edge immune system profiling technology. Discover how we're advancing personalized immunotherapy and enabling real-time clinical decision-making. https://lnkd.in/gf5C4Dfk

Meet us at next week at the 22nd Annual Conference of the Japanese Society for Digital Pathology. BostonGene's Chief Scientific Officer, Joe Lennerz, MD, PhD, will lead a session on the evolving landscape of digital pathology and present two abstracts on AI-based imaging analysis technologies to improve patient care. https://lnkd.in/eZP7ck-3

Brian, we are incredibly inspired by you! You are truly an amazing person in so many ways!

We are excited to announce a partnership with Takeda to optimize patient selection and identify key biomarkers in immuno-oncology focused clinical trials. Read the release: https://lnkd.in/eYU332MX

We’re collaborating with Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, to validate blood- and bone marrow-based assays for hematological cancers. Find out more:  https://lnkd.in/eBZQMKk7